Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase
- 4 December 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in Digestive Diseases and Sciences
- Vol. 53 (4), 997-1012
- https://doi.org/10.1007/s10620-007-0133-6
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Pharmacologic Manipulation of Sphingosine Kinase in Retinal Endothelial Cells: Implications for Angiogenic Ocular DiseasesPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2006
- Biochemical and functional characterization of three activated macrophage populationsJournal of Leukocyte Biology, 2006
- Antitumor Activity of Sphingosine Kinase InhibitorsJournal of Pharmacology and Experimental Therapeutics, 2006
- Lysophosphatidic acid triggers calcium entry through a non-store-operated pathway in human neutrophilsJournal of Leukocyte Biology, 2004
- Sphingosine 1-Phosphate, a Diffusible Calcium Influx Factor Mediating Store-operated Calcium EntryJournal of Biological Chemistry, 2003
- Intestinal oxidative damage in inflammatory bowel disease: semi‐quantification, localization, and association with mucosal antioxidantsThe Journal of Pathology, 2003
- Sphingosine‐1‐phosphate stimulates cortisol secretionFEBS Letters, 2003
- Tumor necrosis factor-α-mediated signal transduction in human neutrophils: Involvement of sphingomyelin metabolites in the priming effect of tnf-α on the fMLP-stimulated superoxide productionLife Sciences, 1999
- Role of Ceramide in Stimulation of the Transcription of Cytosolic Phospholipase A2and Cyclooxygenase 2Biochemical and Biophysical Research Communications, 1996
- Tumor Necrosis Factor-α Activates the Sphingomyelin Signal Transduction Pathway in a Cell-Free SystemScience, 1992